D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.9B |
| 2 |
Broadcom
AVGO
|
+$1.07B |
| 3 |
NVIDIA
NVDA
|
+$908M |
| 4 |
Meta Platforms (Facebook)
META
|
+$861M |
| 5 |
Intuitive Surgical
ISRG
|
+$666M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.68B |
| 2 |
Apple
AAPL
|
+$1.31B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$789M |
| 4 |
GE Aerospace
GE
|
+$653M |
| 5 |
Applovin
APP
|
+$634M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.25% |
| 2 | Consumer Discretionary | 7.51% |
| 3 | Financials | 7.11% |
| 4 | Healthcare | 6.95% |
| 5 | Industrials | 6.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SEI
3676
PUT
Solaris Energy Infrastructure
SEI
$2.9B
| $572K | ﹤0.01% |
+14,300
| New | +$447K |
|
3677
Rollins
ROL
$18.8B
| $571K | ﹤0.01% |
9,725
-93,557
| -91% | -$5.32M |
|
3678
Pharvaris
PHVS
$2.35B
| $571K | ﹤0.01% |
+22,886
| New | +$508K |
|
3679
CALL
Aon
AON
$81.4B
| $571K | ﹤0.01% |
1,600
| – | – |
|
3680
Oaktree Specialty Lending
OCSL
$1.06B
| $569K | ﹤0.01% |
+43,585
| New | +$600K |
|
|
SLVR
3681
Sprott Silver Miners & Physical Silver ETF
SLVR
$612M
| $567K | ﹤0.01% |
+12,791
| New | +$443K |
|
3682
Real Brokerage
REAX
$375M
| $567K | ﹤0.01% |
+135,553
| New | +$612K |
|
3683
Xcel Energy
XEL
$50.1B
| $566K | ﹤0.01% |
7,015
-2,185
| -24% | -$158K |
|
3684
Global X Autonomous & Electric Vehicles ETF
DRIV
$370M
| $564K | ﹤0.01% |
19,950
-1,087
| -5% | -$27.8K |
|
3685
PUT
Golar LNG
GLNG
$4.95B
| $562K | ﹤0.01% |
13,900
+500
| +4% | +$20.7K |
|
|
SKE
3686
Skeena Resources
SKE
$3.28B
| $560K | ﹤0.01% |
30,400
-319,600
| -91% | -$5.23M |
|
3687
State Street SPDR S&P Homebuilders ETF
XHB
$1.69B
| $559K | ﹤0.01% |
+5,049
| New | +$554K |
|
|
BZAIW
3688
Blaize Holdings Warrants
BZAIW
$5.93M
| $559K | ﹤0.01% |
900,000
| – | – |
|
3689
CEVA Inc
CEVA
$883M
| $558K | ﹤0.01% |
21,112
-8,927
| -30% | -$208K |
|
3690
CALL
Winnebago Industries
WGO
$908M
| $555K | ﹤0.01% |
+16,600
| New | +$548K |
|
3691
Lifeway Foods
LWAY
$470M
| $555K | ﹤0.01% |
19,985
-5,308
| -21% | -$149K |
|
|
ESPR
3692
DELISTED
Esperion Therapeutics
ESPR
| $553K | ﹤0.01% |
+208,633
| New | +$404K |
|
3693
Crocs
CROX
$6.75B
| $553K | ﹤0.01% |
+6,615
| New | +$604K |
|
3694
Global X SuperDividend ETF
SDIV
$1.22B
| $552K | ﹤0.01% |
+23,035
| New | +$543K |
|
|
DAWN
3695
DELISTED
Day One Biopharmaceuticals
DAWN
| $550K | ﹤0.01% |
77,972
-3,331
| -4% | -$22.9K |
|
3696
United Parks & Resorts
PRKS
$2.21B
| $550K | ﹤0.01% |
10,632
-1,443
| -12% | -$72.8K |
|
3697
Global X MLP ETF
MLPA
$2.27B
| $546K | ﹤0.01% |
11,272
-2,623
| -19% | -$130K |
|
3698
Bar Harbor Bankshares
BHB
$669M
| $545K | ﹤0.01% |
17,904
+2,537
| +17% | +$79.3K |
|
|
ONC
3699
CALL
BeOne Medicines Ltd
ONC
$34.3B
| $545K | ﹤0.01% |
1,600
| – | – |
|
3700
Black Diamond Therapeutics
BDTX
$101M
| $544K | ﹤0.01% |
143,643
+125,743
| +702% | +$368K |
|
Similar funds
D.E. Shaw & Co's Q3 2025 Portfolio in Review
As of Q3 2025, D.E. Shaw & Co held 5,023 positions worth $177B, up 26% from $141B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
D.E. Shaw & Co deployed $15.2B of net new capital in Q3 2025, opening 714 new positions and adding to 1,743 existing holdings. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 3,319,000 shares worth $370M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.68B trimmed.
- D.E. Shaw & Co's largest Q3 2025 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 3,319,000 shares worth $370M.
- D.E. Shaw & Co added most to Microsoft in Q3 2025, an estimated $1.9B increase.
- D.E. Shaw & Co's biggest Q3 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.68B.
- D.E. Shaw & Co fully exited Hess in Q3 2025, selling an estimated $527M.
- D.E. Shaw & Co's ten largest holdings make up 13% of its $177B portfolio in Q3 2025.
- D.E. Shaw & Co opened 714 new positions and closed 514 in Q3 2025.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $177B.
Based on D.E. Shaw & Co's 13F filing for Q3 2025, filed 14 Nov 2025.